110 related articles for article (PubMed ID: 34592197)
1. The role of cell surface proteins gene expression in diagnosis, prognosis, and drug resistance of colorectal cancer: In silico analysis and validation.
Nazempour N; Taleqani MH; Taheri N; Haji Ali Asgary Najafabadi AH; Shokrollahi A; Zamani A; Fattahi Dolatabadi N; Peymani M; Mahdevar M
Exp Mol Pathol; 2021 Dec; 123():104688. PubMed ID: 34592197
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of basement membrane-related gene based on single-cell and bulk RNA sequencing data to predict prognosis and evaluate immune characteristics in colorectal cancer.
Han J; Wang Q; Li S; Yang J; Qiu Z; Fu W
Environ Toxicol; 2024 Jun; 39(6):3367-3380. PubMed ID: 38445432
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
[TBL] [Abstract][Full Text] [Related]
4. Methylation status of ADAM12 promoter are associated with its expression levels in colorectal cancer.
Wang Y; Zhang J; Cao H; Han F; Zhang H; Xu E
Pathol Res Pract; 2021 May; 221():153449. PubMed ID: 33930608
[TBL] [Abstract][Full Text] [Related]
5. In silico identification of the specific pathways in each stage of colorectal cancer and the association of their top genes with drug resistance and sensitivity.
Hashemi R; Peymani M; Ghaedi K; Saffar H
Med Oncol; 2022 Feb; 39(5):57. PubMed ID: 35150347
[TBL] [Abstract][Full Text] [Related]
6. TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer.
Ren Y; Deng R; Cai R; Lu X; Luo Y; Wang Z; Zhu Y; Yin M; Ding Y; Lin J
Carcinogenesis; 2020 Dec; 41(12):1755-1766. PubMed ID: 32338281
[TBL] [Abstract][Full Text] [Related]
7. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
8. TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers.
Golozar M; Motlagh AV; Mahdevar M; Peymani M; InanlooRahatloo K; Ghaedi K
Exp Mol Pathol; 2024 Apr; 136():104890. PubMed ID: 38378070
[TBL] [Abstract][Full Text] [Related]
9. Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data.
Xiong Y; You W; Wang R; Peng L; Fu Z
Biomed Res Int; 2017; 2017():2421459. PubMed ID: 29209625
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
11. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
Meng H; Li W; Boardman LA; Wang L
BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
[TBL] [Abstract][Full Text] [Related]
12. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
13. Integrated Profiling Identifies
Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
Front Immunol; 2021; 12():722807. PubMed ID: 34646265
[TBL] [Abstract][Full Text] [Related]
14. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
15. Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.
Liu YR; Hu Y; Zeng Y; Li ZX; Zhang HB; Deng JL; Wang G
J Cell Biochem; 2019 Oct; 120(10):18041-18052. PubMed ID: 31297877
[TBL] [Abstract][Full Text] [Related]
16. Two Novel Long Noncoding RNAs - RP11-296E3.2 and LEF1-AS1can - Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer.
Shi Q; He Y; Zhang X; Li J; Cui G; Zhang X; Wang X
Med Sci Monit; 2019 Sep; 25():7042-7051. PubMed ID: 31536481
[TBL] [Abstract][Full Text] [Related]
17. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
18. High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
Chen Z; Wu G; Ye F; Chen G; Fan Q; Dong H; Zhu X; Wu C
BMC Cancer; 2019 May; 19(1):448. PubMed ID: 31088409
[TBL] [Abstract][Full Text] [Related]
19. Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer.
Shi D; Zheng H; Zhuo C; Peng J; Li D; Xu Y; Li X; Cai G; Cai S
Med Oncol; 2014 Jul; 31(7):31. PubMed ID: 24908062
[TBL] [Abstract][Full Text] [Related]
20. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
